Related references
Note: Only part of the references are listed.A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1
Evangelia Loizou et al.
CANCER DISCOVERY (2019)
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
Steffen Boettcher et al.
SCIENCE (2019)
Mutant p53 enhances leukemia-initiating cell self-renewal to promote leukemia development
Sarah C. Nabinger et al.
LEUKEMIA (2019)
Genotoxic stresses promote clonal expansion of hematopoietic stem cells expressing mutant p53
S. Chen et al.
LEUKEMIA (2018)
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
Josephine D. Kahn et al.
BLOOD (2018)
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
Terrence N. Wong et al.
NATURE COMMUNICATIONS (2018)
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
Joanne Hsu et al.
CELL STEM CELL (2018)
Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis
Zhigang Cai et al.
CELL STEM CELL (2018)
WDR68 is essential for the transcriptional activation of the PRC1-AUTS2 complex and neuronal differentiation of mouse embryonic stem cells
Qiang Wang et al.
STEM CELL RESEARCH (2018)
Somatic mutations and clonal hematopoiesis in congenital neutropenia
Jun Xia et al.
BLOOD (2018)
C/EBPα deregulation as a paradigm for leukemogenesis
J. A. Pulikkan et al.
LEUKEMIA (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Jose J. Fuster et al.
SCIENCE (2017)
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling et al.
NATURE REVIEWS CANCER (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy
Miron Prokocimer et al.
BLOOD (2017)
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Florian Zink et al.
BLOOD (2017)
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
J. S. Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
Andrew L. Young et al.
NATURE COMMUNICATIONS (2016)
An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition
Brian Egan et al.
PLOS ONE (2016)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease
Isabel Beerman et al.
CELL STEM CELL (2015)
JMJD3 as an epigenetic regulator in development and disease
Jana S. Burchfield et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
Jiajun Zhu et al.
NATURE (2015)
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
John E. Campbell et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
The role of histone acetyltransferases in normal and malignant hematopoiesis
Xiao-Jian Sun et al.
FRONTIERS IN ONCOLOGY (2015)
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Terrence N. Wong et al.
NATURE (2015)
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rajesh C. Rao et al.
NATURE REVIEWS CANCER (2015)
Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal
Deqiang Sun et al.
CELL STEM CELL (2014)
Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner
Huafeng Xie et al.
CELL STEM CELL (2014)
The H3K27me3 demethylase UTX in normal development and disease
Joni Van der Meulen et al.
EPIGENETICS (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cytokine-Regulated GADD45G Induces Differentiation and Lineage Selection in Hematopoietic Stem Cells
Frederic B. Thalheimer et al.
STEM CELL REPORTS (2014)
Molecular Pathophysiology of Myelodysplastic Syndromes
R. Coleman Lindsley et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 8 (2013)
Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses
Daniela Kenzelmann Broz et al.
GENES & DEVELOPMENT (2013)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
Frank G. Rueckner et al.
BLOOD (2012)
Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells
Takashi Asai et al.
BLOOD (2012)
PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family Complexes
Zhonghua Gao et al.
MOLECULAR CELL (2012)
Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells
Makiko Mochizuki-Kashio et al.
BLOOD (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
p53 Regulates Hematopoietic Stem Cell Quiescence
Yan Liu et al.
CELL STEM CELL (2009)
Moz and Retinoic Acid Coordinately Regulate H3K9 Acetylation, Hox Gene Expression, and Segment Identity
Anne K. Voss et al.
DEVELOPMENTAL CELL (2009)
Mechanisms of Polycomb gene silencing: knowns and unknowns
Jeffrey A. Simon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Adrian P. Bracken et al.
NATURE REVIEWS CANCER (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
When mutants gain new powers: news from the mutant p53 field
Ran Brosh et al.
NATURE REVIEWS CANCER (2009)
The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways
Xiongbin Lu et al.
CANCER AND METASTASIS REVIEWS (2008)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
Stem colls and cancer: The polycomb connection
ME Valk-Lingbeek et al.
CELL (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα.
P Zhang et al.
IMMUNITY (2004)
TP53 in hematological cancer: Low incidence of mutations with significant clinical relevance
S Peller et al.
HUMAN MUTATION (2003)
Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool
JL Luo et al.
ONCOGENE (2001)
Share Paper
